SCHEMBL9253068

SCHEMBL9253068

CCCCCOC1CN(N)CCc2ccccc21

nearest known ligand 0.41

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
CYP2D6 P10635 1/20 0.41
SIGMAR1 Q99720 6/20 0.40
PRCP P42785 1/20 0.37
IDO1 P14902 2/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9626216 0.79 IDO1 (0.51) CYP2D6SIGMAR1IDO1
SCHEMBL10904064 0.76 IDO1 (0.53) CYP2D6SIGMAR1IDO1
SCHEMBL5809770 0.74 HTR2C (0.50) CYP2D6PRCPIDO1
SCHEMBL12228557 0.71 SIGMAR1 (0.40) SIGMAR1IDO1
SCHEMBL10571574 0.71 PRCP (0.43) CYP2D6SIGMAR1PRCP
SCHEMBL11007168 0.70 CYP3A4 (0.42) CYP2D6
SCHEMBL3886571 0.70 SIGMAR1 (0.46) CYP2D6SIGMAR1PRCP
SCHEMBL30728437 0.68 GPR84 (0.57) SIGMAR1IDO1
SCHEMBL19529546 0.66 GPR84 (0.59) IDO1
SCHEMBL20433856 0.66 GPR84 (0.59) IDO1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
JP-5301859-A None JP disclosed
EP-0534344-B1 Substituted 3-amino-2,3,4,5-tetrahydro-1-aryloxy-3-benzazepines, a process for their preparation and their use as modulators of neurotransmitter function HOECHST ROUSSEL PHARMA (US) 1995-02-15 EP disclosed
JP-H05301859-A SUBSTITUTED 3-AMINO-2,3,4,5-TETRAHYDRO-1-ARYLOXY-3-BENZAZEPINES HOECHST ROUSSEL PHARMACEUT INC 1993-11-16 JP disclosed
US-5202319-A Antidepressants HOECHST-ROUSSEL PHARMACEUTICALS INC. (US) 1993-04-13 US disclosed
EP-0534344-A1 Substituted 3-amino-2,3,4,5-tetrahydro-1-aryloxy-3-benzazepines, a process for their preparation and their use as modulators of neurotransmitter function HOECHST-ROUSSEL PHARMACEUTICALS INCORPORATED (US) 1993-03-31 EP disclosed